Photo from wikipedia
The development of novel agents and an ageing population has led to an increasing number of patients with follicular lymphoma (FL) living longer with their disease. Health‐related quality of life… Click to show full abstract
The development of novel agents and an ageing population has led to an increasing number of patients with follicular lymphoma (FL) living longer with their disease. Health‐related quality of life (HRQOL) is a priority for patients and should guide clinical decisions. The Myeloma Patient Outcome Scale (MyPOS), originally developed for myeloma, was validated in a cross‐sectional survey recruiting 124 FL patients.
Keywords:
patients follicular;
myeloma patient;
patient outcome;
follicular lymphoma;
quality life;
outcome scale
Journal Title: European Journal of Haematology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: European Journal of Haematology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!